Eqis Capital Management, Inc. Abiomed Inc Transaction History

Eqis Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 25, 2019	SELL	$281.08 - $444.25 $2.65 Million - $4.19 Million	-9,425 Closed	0 $0
Q3 2018 Oct 17, 2018	BUY	$354.53 - $449.75 $416,572 - $528,456	1,175 Added 14.24%	9,425 $3.88 Million
Q2 2018 Jul 27, 2018	BUY	$278.07 - $446.21 $1.9 Million - $3.06 Million	6,848 Added 488.45%	8,250 $3.37 Million
Q1 2018 Apr 06, 2018	SELL	$192.49 - $295.85 $147,062 - $226,029	-764 Reduced 35.27%	1,402 $408,000
Q4 2017 Jan 25, 2018	BUY	$168.78 - $199.74 $8,101 - $9,587	48 Added 2.27%	2,166 $406,000
Q3 2017 Oct 03, 2017	BUY	$145.39 - $168.6 $307,936 - $357,094	2,118	2,118 $357,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.